A demyelinating disease is any condition that results in damage to the protective covering (myelin sheath) that surrounds nerve fibers in your brain and spinal cord. When the myelin sheath is damaged, nerve impulses slow or even stop, causing neurological problems.
Multiple sclerosis (MS) is the most common demyelinating disease. In this disorder, your immune system attacks the myelin sheath or the cells that produce and maintain it. This causes inflammation and injury to the sheath and ultimately to the nerve fibers that it surrounds, and may result in multiple areas of scarring (sclerosis).
Other types of demyelinating disease and their causes include:
- Optic neuritis — inflammation of the optic nerve in one or both eyes
- Devic disease (neuromyelitis optica) — inflammation of the optic nerve and spinal cord
- Transverse myelitis — inflammation of the spinal cord
- Acute disseminated encephalomyelitis — inflammation of the brain and spinal cord
- Adrenoleukodystrophy and adrenomyeloneuropathy — rare, inherited metabolic disorders
MS and other demyelinating diseases may result in vision or hearing loss, headache, seizures, muscle spasms and weakness, loss of coordination, paralysis, and loss of sensation.
No cures exist for demyelinating diseases and their progression, and symptoms are different for everyone. Getting treatment early is important. Treatment focuses on:
- Minimizing the effects of the attacks
- Modifying the course of the disease
- Managing the symptoms
A variety of drug therapies are recommended depending on your specific disorder. These may include medications that decrease the frequency of new lesion formation. Strategies to treat symptoms include physical therapy, muscle relaxing drugs, and medications to reduce pain and fatigue. Talk with your doctor about the best course of treatment for your specific disorder.
May. 19, 2011
See more Expert Answers
- Frosch MP, et al. The central nervous system. In: Kumar V, et al. Robbins and Cotran: Pathologic Basis of Disease. 8th ed. Philadelphia, Pa.: Elsevier Saunders; 2010. http://www.mdconsult.com/books/page.do?eid=4-u1.0-B978-1-4377-0792-2..50033-X&isbn=978-1-4377-0792-2&type=bookPage§ionEid=4-u1.0-B978-1-4377-0792-2..50033-X&uniqId=237845970-8. Accessed March 23, 2011.
- Ferri FF. Demyelinating diseases. In: Ferri FF. Ferri's Clinical Advisor 2011: Instant Diagnosis and Treatment. Philadelphia, Pa.: Mosby Elsevier; 2011. http://www.mdconsult.com/books/about.do?eid=4-u1.0-B978-0-323-05610-6..C2009-0-38600-6--TOP&isbn=978-0-323-05610-6&about=true&uniqId=230100505-53. Accessed March. 23, 2011.
- Olek MJ. Epidemiology, risk factors and clinical features of multiple sclerosis in adults. http://www.uptodate.com/home/index.html. Accessed March 24, 2011.
- NINDS neuromyelitis optica information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/neuromyelitis_optica/neuromyelitis_optica.htm. Accessed March 24, 2011.
- NINDS adrenoleukodystrophy information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/adrenoleukodystrophy/adrenoleukodystrophy.htm. Accessed March 24, 2011.
- Maertens P, et al. Storage diseases: Neuronal ceroid-lipofuscinoses, lipidoses, glycogenoses and leukodystrophies. In: Goetz CG. Textbook of Clinical Neurology. 3rd ed. Philadelphia, Pa.: Saunders Elsevier; 2007:613
- Ropper AH, et al. Multiple sclerosis and allied demyelinating diseases. In: Ropper AH, et al. Adams & Victor's Principles of Neurology. 9th ed. New York, N.Y.: The McGraw-Hill Companies; 2009. http://accessmedicine.com/content.aspx?aID=3638768&searchStr=demyelinating+disease#3638768. AccessedMarch 24, 2011.
- Treatments for multiple sclerosis. Multiple Sclerosis Foundation. http://www.msfocus.org/Treatments-for-multiple-sclerosis.aspx. Accessed March 25, 2011.